The Ontario Neurodegenerative Disease Research Initiative
暂无分享,去创建一个
Christopher J. M. Scott | John F. Robinson | Allison A. Dilliott | M. Freedman | W. McIlroy | D. Munoz | S. Strother | A. Troyer | M. Montero‐Odasso | R. Bartha | M. Borrie | R. Swartz | R. Hegele | M. Jog | E. Rogaeva | W. Hatch | D. Munoz | T. Rajji | B. Coe | M. Tartaglia | M. Masellis | E. Finger | S. Arnott | M. Binns | G. Saposnik | M. Strong | L. Zinman | J. Turnbull | D. Grimes | J. Ramirez | D. Brien | C. Scott | Sanjeev Kumar | D. Beaton | S. Pasternak | C. Shoesmith | T. Steeves | D. Sahlas | W. Lou | P. McLaughlin | D. Seitz | D. Tang‐Wai | S. Symons | C. Marras | J. Orange | B. Levine | J. Mandzia | D. Kwan | L. Casaubon | Barry D. Greenberg | A. Roberts | B. Cornish | K. Sunderland | Chris Hudson | P. Kleinstiver | F. Faria | J. Lawrence-Dewar | Corinne Fischer | D. Dowlatshahi | Julia Fraser | David S. Park | S. Black | B. Tan | A. Frank | A. Hassan | A. Lang | A. Dilliott | J. Lawrence‐Dewar | Doug Munoz | D. Munoz | Dara P. Dowlatshahi
[1] S. Strother,et al. The Quality Assurance and Quality Control Protocol for Neuropsychological Data Collection and Curation in the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study , 2020, Assessment.
[2] Corinne E. Fischer,et al. Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer’s Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years , 2020, Journal of Alzheimer's disease : JAD.
[3] Stephen C. Strother,et al. An overview of the quality assurance and quality control of magnetic resonance imaging data for the Ontario Neurodegenerative Disease Research Initiative (ONDRI): pipeline development and neuroinformatics , 2020, bioRxiv.
[4] Seyyed M H Haddad,et al. Comparison of quality control methods for automated diffusion tensor imaging analysis pipelines , 2019, PloS one.
[5] Melissa F. Holmes,et al. Ontario Neurodegenerative Disease Research Initiative (ONDRI): Structural MRI methods & outcome measures , 2019, bioRxiv.
[6] D. Stuss,et al. APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia , 2019, Neurology.
[7] Bryan M. Wong,et al. Validation of Optical Coherence Tomography Retinal Segmentation in Neurodegenerative Disease , 2019, Translational vision science & technology.
[8] Lorne Zinman,et al. The utility of multivariate outlier detection techniques for data quality evaluation in large studies: an application within the ONDRI project , 2019, BMC Medical Research Methodology.
[9] Maxime Descoteaux,et al. The Canadian Dementia Imaging Protocol: Harmonizing National Cohorts , 2018, Journal of magnetic resonance imaging : JMRI.
[10] Norbert Schuff,et al. The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort , 2018, Annals of clinical and translational neurology.
[11] S. Love,et al. A broader view of dementia: multiple co-pathologies are the norm. , 2018, Brain : a journal of neurology.
[12] Stephen C. Strother,et al. Generalization of the minimum covariance determinant algorithm for categorical and mixed data types , 2018, bioRxiv.
[13] Stephen C. Strother,et al. Brain-CODE: A Secure Neuroinformatics Platform for Management, Federation, Sharing and Analysis of Multi-Dimensional Neuroscience Data , 2018, Front. Neuroinform..
[14] Ming Zhang,et al. Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease , 2018, Journal of visualized experiments : JoVE.
[15] Angus Silver,et al. NeuroMatic: An Integrated Open-Source Software Toolkit for Acquisition, Analysis and Simulation of Electrophysiological Data , 2018, Front. Neuroinform..
[16] Norbert Schuff,et al. Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort , 2018, Movement disorders : official journal of the Movement Disorder Society.
[17] Dimo Ivanov,et al. Determining Excitatory and Inhibitory Neuronal Activity from Multimodal fMRI Data Using a Generative Hemodynamic Model , 2017, Front. Neurosci..
[18] N. Greig,et al. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview. , 2017, Current Alzheimer research.
[19] D. Aarsland,et al. Maximizing the Potential of Longitudinal Cohorts for Research in Neurodegenerative Diseases: A Community Perspective , 2017, Front. Neurosci..
[20] D. Krewski,et al. Burden of neurological conditions in Canada , 2017, Neurotoxicology.
[21] Douglas P. Munoz,et al. Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI) , 2017, Journal of Alzheimer's disease : JAD.
[22] Lorne Zinman,et al. The Ontario Neurodegenerative Disease Research Initiative (ONDRI) , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[23] John F. Robinson,et al. The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration , 2016, npj Genomic Medicine.
[24] Yee-Hong Yang,et al. Cerebral Degeneration in Amyotrophic Lateral Sclerosis Revealed by 3-Dimensional Texture Analysis , 2016, Front. Neurosci..
[25] L. Clare,et al. Cognitive reserve and cognitive function in healthy older people: a meta-analysis , 2016, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.
[26] Arthur W. Toga,et al. Sharing data in the global alzheimer's association interactive network , 2016, NeuroImage.
[27] C. Belden,et al. Age- and education-adjusted normative data for the Montreal Cognitive Assessment (MoCA) in older adults age 70–99 , 2015, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.
[28] Veronica Redaelli,et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis , 2015, The Lancet Neurology.
[29] M. Borrie,et al. Primary Care–Based Memory Clinics: Expanding Capacity for Dementia Care* , 2014, Canadian Journal on Aging / La Revue canadienne du vieillissement.
[30] Isabelle Vedel,et al. Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: recommendations for family physicians. , 2014, Canadian family physician Medecin de famille canadien.
[31] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[32] Cheryl Cook,et al. Knowledge translation: an overview and recommendations in relation to the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia , 2013, Alzheimer's Research & Therapy.
[33] O. Hardiman,et al. Cognitive changes predict functional decline in ALS , 2013, Neurology.
[34] Mark Hallett,et al. Criteria for the diagnosis of corticobasal degeneration , 2013, Neurology.
[35] J. Karlawish,et al. Are Patients Whose Study Partners Are Spouses More Likely to be Eligible for Alzheimer’s Disease Clinical Trials , 2012, Dementia and Geriatric Cognitive Disorders.
[36] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[37] J. Perlmutter,et al. Neurologist care in Parkinson disease , 2011, Neurology.
[38] Nick C Fox,et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[39] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[40] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[41] C. Jack,et al. Alzheimer's Disease Neuroimaging Initiative (ADNI) , 2010, Neurology.
[42] K. Huybrechts,et al. The Prognostic Value of the Modified Rankin Scale Score for Long-Term Survival after First-Ever Stroke , 2008, Cerebrovascular Diseases.
[43] David A. Bennett,et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.
[44] F. Murtagh. Multiple correspondence analysis and related methods , 2007 .
[45] M. Greenacre,et al. Multiple Correspondence Analysis and Related Methods , 2006 .
[46] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[47] M. Naumann,et al. Disease progression in amyotrophic lateral sclerosis: Predictors of survival , 2002, Muscle & nerve.
[48] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[49] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.